# Gemini Pharmaceuticals, Inc. – FDA Inspection, Feb 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/5f815dde-5720-44ae-a6e5-ab350f64a85e
Source feed: FDA_Inspections

> FDA inspection 1041525 of Gemini Pharmaceuticals, Inc., February 16, 2018. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041525
- Company Name: Gemini Pharmaceuticals, Inc.
- Inspection Date: 2018-02-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1317530 - 2026-05-15](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/3c2276f9-a20a-4803-a2e7-9277b1bf2a74)
- FDA Inspection 1175407 - 2022-07-26
- FDA Inspection 1064447 - 2018-08-23
- [FDA Inspection 936886 - 2015-06-30](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/6d577591-8391-4524-a2b4-21427df5636b)
- [FDA Inspection 856101 - 2013-11-08](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/a0e9984c-d1de-458a-8f0d-9838d2949911)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/christopher-s-fields/066519e8-20eb-4c41-aaf6-5b17348a0409)
- [Company Rep](https://www.keypedia.com/people/jose-o-hernandez/960bffbe-1b8e-41bc-b203-aee88d7d8dac)

Company: https://www.keypedia.com/companies/gemini-pharmaceuticals-inc/9e83f65c-3863-4ad6-a434-b37d9673ac0f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c